T2 Biosystems Inc. (TTOO)
OTC: TTOO
· Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM
T2 Biosystems Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.99M | 1.95M | 2.06M | 1.68M | 1.47M | 1.96M | 2.08M | 5.48M | 3.68M | 5.91M | 7.23M | 6.98M | 7.43M | 6.69M | 6.96M |
Cost of Revenue | 4.1M | 2.69M | 4.2M | 2.65M | 3.92M | 4.87M | 4M | 3.73M | 6.08M | 5.08M | 6.21M | 5.36M | 4.72M | 4.83M | 5.79M |
Gross Profit | -2.12M | -741K | -2.14M | -969K | -2.45M | -2.9M | -1.92M | 1.75M | -2.41M | 830K | 1.03M | 1.62M | 2.71M | 1.86M | 1.17M |
Operating Income | -10.16M | -9.57M | -12.6M | -9.32M | -13.61M | -13.05M | -13.69M | -9.52M | -15.8M | -15.02M | -14.86M | -10.28M | -12.21M | -10.78M | -9.7M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 2K | n/a | 2K | 1K | 2K | 3K | 94K | 6K | 6K | 6K |
Pretax Income | -10.12M | -8.96M | -13.53M | -10.34M | -15.43M | -6.35M | -17.96M | -10.1M | -17.38M | -18.03M | -16.5M | -12.14M | -13.96M | -12.47M | -10.66M |
Net Income | -10.12M | -8.96M | -13.53M | -10.34M | -15.43M | -6.35M | -17.96M | -10.1M | -18.95M | -21.05M | -18.13M | -12.14M | -13.96M | -12.47M | -10.66M |
Selling & General & Admin | 5.38M | 5.47M | 6.74M | 5.25M | 5.98M | 6.3M | 7.3M | 6.55M | 7.02M | 7.82M | 9.23M | 6.54M | 8.54M | 7.24M | 6.2M |
Research & Development | 2.67M | 3.36M | 3.72M | 3.1M | 2.66M | 3.85M | 4.47M | 4.72M | 6.38M | 8.03M | 6.66M | 5.35M | 6.38M | 5.4M | 4.67M |
Other Expenses | n/a | n/a | 325K | 109K | 2.51M | 29K | n/a | n/a | -77K | 4K | -2K | -5K | n/a | n/a | 49K |
Operating Expenses | 8.04M | 8.83M | 10.46M | 8.35M | 11.15M | 10.15M | 11.77M | 11.27M | 13.39M | 15.85M | 15.89M | 11.9M | 14.92M | 12.64M | 10.87M |
Interest Expense | 370K | 478K | 1.18M | 1.16M | 1.12M | 1.54M | 1.52M | 1.53M | 1.56M | 1.35M | 1.65M | 1.95M | 1.92M | 1.7M | 1.01M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.15M | 11.53M | 14.66M | 11M | 15.08M | 15.02M | 15.77M | 15M | 19.48M | 20.93M | 22.09M | 17.26M | 19.64M | 17.47M | 16.66M |
Income Tax Expense | n/a | n/a | -64K | -3.38M | -262K | 1.57M | n/a | n/a | 1.57M | 3.02M | 1.64M | 1.95M | 1.92M | 1.7M | 251K |
Shares Outstanding (Basic) | 17.89M | 14.1M | 5.09M | 4.97M | 4.48M | 809.17K | 136.33K | 74.06K | 60.02K | 35.36K | 33.97K | 33.23K | 33.16K | 30.98K | 29.65K |
Shares Outstanding (Diluted) | 17.89M | 14.1M | 5.09M | 4.97M | 4.48M | 809.17K | 136.33K | 74.06K | 60.09K | 35.36K | 33.97K | 33.23K | 33.18K | 30.98K | 29.65K |
EPS (Basic) | -0.57 | -0.64 | -2.66 | -2.08 | -3.45 | -7.84 | -131.77 | -136.37 | -315.75 | -595.33 | -533.78 | -365.41 | -421.01 | -402.72 | -359.58 |
EPS (Diluted) | -0.57 | -0.64 | -2.66 | -2.08 | -3.45 | -7.84 | -131.77 | -136.37 | -315.37 | -595.33 | -533.78 | -365.4 | -420.85 | -402.72 | -359.58 |
EBITDA | -9.69M | -8.42M | -12.29M | -9.11M | -14.04M | -4.21M | -16.19M | -8M | -15.55M | -16.14M | -14.56M | -9.63M | -11.46M | -10.01M | -8.84M |
EBIT | -9.75M | -8.48M | -12.36M | -9.18M | -14.31M | -4.81M | -16.44M | -8.57M | -15.81M | -16.69M | -14.85M | -10.19M | -12.04M | -10.59M | -9.65M |
Depreciation & Amortization | 59K | 62K | 64K | 74K | 262K | 599K | 256K | 572K | 570K | 549K | 580K | 556K | 584K | 587K | 811K |